CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
POPEYE introduces a novel treatment for glaucoma that focuses on promoting recovery through axon regeneration and neural circuit reconstruction. This innovative approach aims to address the limitations of existing therapies that only slow disease progression without reversing damage.
Vision enables 70% of our sensorial interactions with the outside world, making blindness a devastating condition with profound impact on quality of life.
Glaucoma, the second leading cause of blindness globally after cataracts, affects over 80 million people worldwide, including more than 1 million in France alone.
The disease impacts approximately 2% of the population over 40 years old and 10% of those over 70.
With an aging global population, these numbers are projected to rise significantly…
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
